Gisela Schwab is President & CMO at EXELIXIS, INC. (EXEL). They have made 35 open-market trades across 1 company since 2009, most recently 2021-07-26.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $110K since 2012, against 34 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EXEL | 689,078 | $42.9M |
Shares reported on the most recent Form 4, priced at the 2021-07-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EXEL | SELL | 2021-05-13 | 2021-05-14 | $25.38 | $2.5M | -12.3% | -10.9% | -29.6% |
| EXEL | SELL | 2021-04-26 | 2021-04-28 | $25.00 | $1.3M | +0.7% | -9.0% | -32.8% |
| EXEL | SELL | 2021-04-01 | 2021-04-02 | $23.00 | $1.1M | +4.7% | +7.8% | -18.8% |
| EXEL | SELL | 2021-02-17 | 2021-02-19 | $22.43 | $2.2M | -3.0% | +7.5% | +10.7% |
| EXEL | SELL | 2020-06-04 | 2020-06-05 | $22.96 | $2.3M | -0.2% | +2.8% | -7.9% |
| EXEL | SELL | 2020-04-23 | 2020-04-24 | $26.00 | $2.6M | -2.5% | -9.5% | -7.0% |
| EXEL | SELL | 2020-03-04 | 2020-03-06 | $19.47 | $2.9M | -16.4% | +0.7% | +28.7% |
| EXEL | SELL | 2020-02-19 | 2020-02-21 | $21.50 | $860K | -2.2% | -24.6% | +21.0% |
| EXEL | SELL | 2020-02-07 | 2020-02-07 | $18.37 | $919K | +12.5% | -7.3% | +32.5% |
| EXEL | SELL | 2020-01-07 | 2020-01-09 | $17.96 | $898K | +5.5% | +2.7% | -0.4% |
| EXEL | SELL | 2019-12-03 | 2019-12-05 | $16.22 | $811K | +3.6% | +1.5% | +15.0% |
| EXEL | SELL | 2019-11-04 | 2019-11-06 | $15.99 | $800K | +6.2% | +13.6% | +15.2% |
| EXEL | SELL | 2019-10-01 | 2019-10-03 | $17.87 | $536K | -6.5% | -10.4% | -1.7% |
| EXEL | SELL | 2019-04-03 | 2019-04-03 | $25.00 | $1.6M | -7.2% | -16.2% | -14.6% |
| EXEL | SELL | 2019-03-25 | 2019-03-27 | $23.14 | $2.3M | +4.9% | -11.8% | -9.3% |
| EXEL | SELL | 2019-02-14 | 2019-02-15 | $21.76 | $2.7M | +1.3% | +9.2% | -10.5% |
| EXEL | SELL | 2018-12-03 | 2018-12-03 | $21.02 | $567K | -2.0% | -7.2% | +5.1% |
| EXEL | SELL | 2018-11-01 | 2018-11-02 | $14.16 | $170K | -4.2% | +22.9% | +34.7% |
| EXEL | SELL | 2018-10-01 | 2018-10-03 | $17.77 | $213K | -12.3% | -3.9% | +10.0% |
| EXEL | SELL | 2018-09-04 | 2018-09-06 | $18.53 | $417K | -10.2% | -6.5% | +13.7% |
| EXEL | SELL | 2018-08-01 | 2018-08-03 | $20.56 | $463K | -5.5% | -9.3% | -27.3% |
| EXEL | SELL | 2018-07-02 | 2018-07-03 | $21.20 | $477K | -2.7% | +3.5% | -17.6% |
| EXEL | SELL | 2018-06-01 | 2018-06-01 | $20.80 | $468K | -6.5% | +5.2% | -6.3% |
| EXEL | SELL | 2018-05-03 | 2018-05-04 | $23.09 | $519K | -9.3% | -10.6% | -0.5% |
| EXEL | SELL | 2017-09-28 | 2017-09-28 | $23.74 | $791K | +7.3% | +7.9% | +27.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.